BackNeurogene Overview
Neurogene Inc

Neurogene Target Price

Analysts' average 12-month price target for Neurogene is $71.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.41

Average Target Price

$71.0084.8% upside

5 analysts in the last 4 months

High: $81 | Low: $65

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-12H.C. WainwrightMitchel Kapoor$6569.2% upsideOpen
2026-08-12GuggenheimDebjit Chattopadhyay$81110.9% upsideOpen
2026-06-09H.C. WainwrightMitchel Kapoor$7082.2% upsideOpen
2026-06-03UBS$7082.2% upsideOpen
2026-04-28Guggenheim$6979.6% upsideOpen
2025-10-02H.C. Wainwright$4517.2% upsideOpen
2025-04-14BMO CapitalKeith Tapper$1658.3% downsideOpen
2025-03-25Robert W. BairdJoel Beatty$381.1% downsideOpen
2025-03-25H.C. WainwrightMitchell Kapoor$5030.2% upsideOpen
2024-11-20Stifel NicolausPaul Matteis$4619.8% upsideOpen
2024-11-19BMO CapitalKeith Tapper$4517.2% upsideOpen
2024-11-12BMO CapitalKeith Tapper$6056.2% upsideOpen
2024-11-12Stifel NicolausPaul Matteis$6056.2% upsideOpen
2024-08-12H.C. WainwrightMitchell Kapoor$4927.6% upsideOpen
2024-06-26BMO CapitalKeith Tapper$6569.2% upsideOpen
2024-06-10Robert W. BairdJoel Beatty$5440.6% upsideOpen
2024-05-13H.C. WainwrightMitchel Kapoor$5132.8% upsideOpen

Neurogene (NGNE) FAQ

The latest target price for NGNE is $71. Investors often review this figure alongside Neurogene's historical trend and sector peers before judging valuation or financial health.

Neurogene trades near $38.41 while the consensus target sits at $71 (84.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting NGNE's target price ($71), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Neurogene's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.